Yeast in the urine: Solutions for a budding problem

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The significance of candiduria ranges from simple procurement-related contamination to disseminated candidiasis. Ensuring that a valid urine specimen is collected and carefully assessing patients for risk factors predisposing to disseminated candidiasis permit the stratificationof cases into three clinical categories: (1) asymptomatic candiduria in a previously healthy patient; (2) candiduria in a high-risk patient in whom disseminated candidiasis is unlikely; and (3) candiduria in a high-risk patient with a potential for disseminated candidiasis. Strategies for managementare tailored to the individual patient. Appropriate management of anatomic genitourinary abnormalities and removal of bladder catheters may result in the resolution of candiduria, although some patients require systemic antifungal therapy. All patients with candiduria should be evaluated for evidence of deep-seated tissue infection or candidemia before therapy is instituted. Fluconazole appears to be a safe and effective agent for the management of candidal urinary tract infection. Bothits safety and its ease of administration make it superior to amphotericin B for this purpose.

Original languageEnglish (US)
Pages (from-to)183-189
Number of pages7
JournalClinical Infectious Diseases
Volume20
Issue number1
DOIs
StatePublished - Jan 1 1995

Fingerprint

Yeasts
Urine
Candidiasis
Urogenital Abnormalities
Candidemia
Fluconazole
Amphotericin B
Urinary Tract Infections
Urinary Bladder
Catheters
Safety
Therapeutics
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Yeast in the urine : Solutions for a budding problem. / Fisher, John Fremont; Newman, Cheryl L; Sobel, Jack D.

In: Clinical Infectious Diseases, Vol. 20, No. 1, 01.01.1995, p. 183-189.

Research output: Contribution to journalArticle

@article{bcaaad1795fe4e2b9eebc0af068491b6,
title = "Yeast in the urine: Solutions for a budding problem",
abstract = "The significance of candiduria ranges from simple procurement-related contamination to disseminated candidiasis. Ensuring that a valid urine specimen is collected and carefully assessing patients for risk factors predisposing to disseminated candidiasis permit the stratificationof cases into three clinical categories: (1) asymptomatic candiduria in a previously healthy patient; (2) candiduria in a high-risk patient in whom disseminated candidiasis is unlikely; and (3) candiduria in a high-risk patient with a potential for disseminated candidiasis. Strategies for managementare tailored to the individual patient. Appropriate management of anatomic genitourinary abnormalities and removal of bladder catheters may result in the resolution of candiduria, although some patients require systemic antifungal therapy. All patients with candiduria should be evaluated for evidence of deep-seated tissue infection or candidemia before therapy is instituted. Fluconazole appears to be a safe and effective agent for the management of candidal urinary tract infection. Bothits safety and its ease of administration make it superior to amphotericin B for this purpose.",
author = "Fisher, {John Fremont} and Newman, {Cheryl L} and Sobel, {Jack D.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1093/clinids/20.1.183",
language = "English (US)",
volume = "20",
pages = "183--189",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Yeast in the urine

T2 - Solutions for a budding problem

AU - Fisher, John Fremont

AU - Newman, Cheryl L

AU - Sobel, Jack D.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The significance of candiduria ranges from simple procurement-related contamination to disseminated candidiasis. Ensuring that a valid urine specimen is collected and carefully assessing patients for risk factors predisposing to disseminated candidiasis permit the stratificationof cases into three clinical categories: (1) asymptomatic candiduria in a previously healthy patient; (2) candiduria in a high-risk patient in whom disseminated candidiasis is unlikely; and (3) candiduria in a high-risk patient with a potential for disseminated candidiasis. Strategies for managementare tailored to the individual patient. Appropriate management of anatomic genitourinary abnormalities and removal of bladder catheters may result in the resolution of candiduria, although some patients require systemic antifungal therapy. All patients with candiduria should be evaluated for evidence of deep-seated tissue infection or candidemia before therapy is instituted. Fluconazole appears to be a safe and effective agent for the management of candidal urinary tract infection. Bothits safety and its ease of administration make it superior to amphotericin B for this purpose.

AB - The significance of candiduria ranges from simple procurement-related contamination to disseminated candidiasis. Ensuring that a valid urine specimen is collected and carefully assessing patients for risk factors predisposing to disseminated candidiasis permit the stratificationof cases into three clinical categories: (1) asymptomatic candiduria in a previously healthy patient; (2) candiduria in a high-risk patient in whom disseminated candidiasis is unlikely; and (3) candiduria in a high-risk patient with a potential for disseminated candidiasis. Strategies for managementare tailored to the individual patient. Appropriate management of anatomic genitourinary abnormalities and removal of bladder catheters may result in the resolution of candiduria, although some patients require systemic antifungal therapy. All patients with candiduria should be evaluated for evidence of deep-seated tissue infection or candidemia before therapy is instituted. Fluconazole appears to be a safe and effective agent for the management of candidal urinary tract infection. Bothits safety and its ease of administration make it superior to amphotericin B for this purpose.

UR - http://www.scopus.com/inward/record.url?scp=0028852828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028852828&partnerID=8YFLogxK

U2 - 10.1093/clinids/20.1.183

DO - 10.1093/clinids/20.1.183

M3 - Article

C2 - 7727650

AN - SCOPUS:0028852828

VL - 20

SP - 183

EP - 189

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -